Author Topic: MIT Cuts Ties with Nectome  (Read 550 times)

0 Members and 1 Guest are viewing this topic.

Offline Femacamper

  • Member
  • *****
  • Posts: 10,398
  • TRUNEWS
    • TRUNEWS
MIT Cuts Ties with Nectome
« on: April 04, 2018, 10:21:23 pm »

The biotech startup plans to ‘preserve memories’ to make human brains ‘immortal.’

MIT has announced it will no longer associate with the startup Nectome that has been promoting a “100-percent fatal” procedure that might preserve customers’ brains for possible future digital upload.

As TruNews reported last month, Nectome’s process involves connecting terminally ill patients to a machine that pumps embalming fluids into their arteries. These fluids are supposed to preserve the memories of the brain in such a way as that they could later be digitally uploaded into a device or “humanoid” robot, creating a form of “immortality.”

MIT was heavily criticized for its involvement in the project, which is still based on as-yet unproven technology. The MIT Media Lab, which obtained a federal grant won by Nectome’s co-founders, who are graduates of the university, issued a statement, which reads, in part:

“Upon consideration of the scientific premises underlying the company’s commercial plans, as well as certain public statements that the company has made, MIT has informed Nectome of its intent to terminate the subcontract between MIT and Nectome in accordance with the terms of their agreement.

“Neuroscience has not sufficiently advanced to the point where we know whether any brain preservation method is powerful enough to preserve all the different kinds of biomolecules related to memory and the mind. It is also not known whether it is possible to recreate a person’s consciousness.”

The statement further noted that scientists cannot “directly measure or create consciousness,” although it might be possible one day. But, even then, it questions whether or not such a construct would be a real consciousness or simply a simulation

Nectome has since updated its website to note that “in response to recent press,” it would only carry out its procedure on human beings only after additional research has been conducted.

Content Contributed By — TruNews Team
Provided by — TruNews